Acute severe renal failure in a patient receiving apixaban: a case report
Because there is little clinical experience with apixaban in patients with severe renal impairment and non-valvular atrial fibrillation, the European Medicines Agency does not advise using it to prevent strokes in these patients. However, only a small number of pharmacokinetic and pharmacodynamic i...
Main Authors: | Attilia Maria Pizzini, Chiara Fantoni, Stefania Zaccaroni, Mauro Silingardi |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2024-04-01
|
Series: | Italian Journal of Medicine |
Subjects: | |
Online Access: | https://www.italjmed.org/ijm/article/view/1718 |
Similar Items
-
Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report
by: Vittorio Dalmastri, et al.
Published: (2023-07-01) -
Effective Apixaban removal using hemoadsorption during emergent open-heart surgery: a case report and narrative literature review
by: Vitor Mendes, et al.
Published: (2024-04-01) -
Apixaban
by: Gianluca Airoldi, et al.
Published: (2013-03-01) -
Traumatic Pseudoaneursym of Superficial Temporal Artery in an Octogenarian Patient Under Apixaban Therapy
by: Sertan Özyalçın, et al.
Published: (2020-02-01) -
Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis
by: Chen I. Tseng, et al.
Published: (2023-02-01)